1
|
Baguet JP, Barone-Rochette G, Tamisier R,
Levy P and Pépin JL: Mechanisms of cardiac dysfunction in
obstructive sleep apnea. Nat Rev Cardiol. 9:679–688. 2012.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Beaudin AE, Pun M, Yang C, Nicholl DD,
Steinback CD, Slater DM, Edwards KE Wynne, Hanly PJ, Ahmed SB and
Poulin MJ: Cyclooxygenases 1 and 2 differentially regulate blood
pressure and cerebrovascular responses to acute and chronic
intermittent hypoxia: Implications for sleep apnea. J Am Heart
Assoc. 3:e0008752014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Chen L, Zhang J, Gan TX, Chen-Izu Y,
Hasday JD, Karmazyn M, Balke CW and Scharf SM: Left ventricular
dysfunction and associated cellular injury in rats exposed to
chronic intermittent hypoxia. J Appl Physiol (1985). 104:218–223.
2008. View Article : Google Scholar : PubMed/NCBI
|
4
|
Yeung HM, Hung MW, Lau CF and Fung ML:
Cardioprotective effects of melatonin against myocardial injuries
induced by chronic intermittent hypoxia in rats. J Pineal Res.
58:12–25. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Fu J, Lin G, Wu Z, Ceng B, Wu Y, Liang G,
Qin G, Li J, Chiu I and Liu D: Anti-apoptotic role for C1 inhibitor
in ischemia/reperfusion-induced myocardial cell injury. Biochem
Biophys Res Commun. 349:504–12. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Fu J, Lin G, Zeng B, Wu Z, Wu Y, Chu H,
Qin G, Liang G, Li J, Gan X, et al: Anti-ischemia/reperfusion of C1
inhibitor in myocardial cell injury via regulation of local
myocardial C3 activity. Biochem Biophys Res Commun. 350:162–168.
2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Chen L, Zhang J, Hu X, Philipson KD and
Scharf SM: The Na+/Ca2+ exchanger-1 mediates
left ventricular dysfunction in mice with chronic intermittent
hypoxia. J Appl Physiol (1985). 109:1675–1685. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Liu D, Zhang D, Scafidi J, Wu X, Cramer CC
and Davis AE: 3rd: C1 inhibitor prevents Gram-negative bacterial
lipopolysaccharide-induced vascular permeability. Blood.
105:2350–2355. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Buerke M..Schwertz H..Seitz W..Meyer
J..Darius H.: Novel small molecule inhibitor of C1s exerts
cardioprotective effects in ischemia–reperfusion injury in rabbits.
J Immunol. 167:5375–5380. 2001. View Article : Google Scholar : PubMed/NCBI
|
10
|
Konings J, Govers-Riemslag JW, Spronk HM,
Waltenberger JL and ten Cate H: Activation of the contact system in
patients with a first acute myocardial infarction. Thromb Res.
132:138–142. 2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Onat A, Can G, Rezvani R and Cianflone K:
Complement C3 and cleavage products in cardiometabolic risk. Clin
Chim Acta. 412:1171–1179. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Uyar IS, Onal S, Akpinar MB, Gonen I,
Sahin V, Uguz AC and Burma O: Alpha lipoic acid attenuates
inflammatory response during extracorporeal circulation. Cardiovasc
J Afr. 24:322–326. 2013. View Article : Google Scholar : PubMed/NCBI
|
13
|
Lu F, Fernandes SM and Davis AE III: The
effect of C1 inhibitor on myocardial ischemia and reperfusion
injury. Cardiovasc Pathol. 22:75–80. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Shi H, Williams JA, Guo L, Stampoulis D,
Cordeiro M Francesca and Moss SE: Exposure to the complement C5b-9
complex sensitizes 661W photoreceptor cells to both apoptosis and
necroptosis. Apoptosis. 20:433–443. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Ding W and Zhang X, Huang H, Ding N, Zhang
S, Hutchinson SZ and Zhang X: Adiponectin protects rat myocardium
against chronic intermittent hypoxia-induced injury via inhibition
of endoplasmic reticulum stress. PLoS One. 9:e945452014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wang M, Lu L, Liu Y, Gu G and Tao R:
FTY720 attenuates hypoxia-reoxygenation-induced apoptosis in
cardiomyocytes. Exp Mol Pathol. 97:218–224. 2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Caliezi C, Zeerleder S, Redondo M, Regli
B, Rothen HU, Zürcher-Zenklusen R, Rieben R, Devay J, Hack CE,
Lämmle B and Wuillemin WA: C1-inhibitor in patients with severe
sepsis and septic shock: Beneficial effect on renal dysfunction.
Crit Care Med. 30:1722–1728. 2002. View Article : Google Scholar : PubMed/NCBI
|
18
|
Emlen W, Li W and Kirschfink M:
Therapeutic complement inhibition: New developments. Semin Thromb
Hemost. 36:660–668. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Bäck J, Lood C, Bengtsson AA, Ekdahl KN
and Nilsson B: Contact activation products are new potential
biomarkers to evaluate the risk of thrombotic events in systemic
lupus erythematosus. Arthritis Res Ther. 15:R2062013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Marcheix B, Carrier M, Martel C, Cossette
M, Pellerin M, Bouchard D and Perrault LP: Effect of pericardial
blood processing on postoperative inflammation and the complement
pathways. Ann Thorac Surg. 85:530–535. 2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Collard CD, Väkevä A, Büküsoglu C, Zünd G,
Sperati CJ, Colgan SP and Stahl GL: Reoxygenation of hypoxic human
umbilical vein endothelial cells activates the classic complement
pathway. Circulation. 96:326–333. 1997. View Article : Google Scholar : PubMed/NCBI
|
22
|
Devlin LA, Nguyen MD, Figueroa E, Gordon
LE, Feldhoff PW and Lassiter HA: Effects of endotoxin
administration and cerebral hypoxia-ischemia on complement activity
and local transcriptional regulation in neonatal rats. Neurosci
Lett. 390:109–113. 2005. View Article : Google Scholar : PubMed/NCBI
|
23
|
Bengtson A, Millocco I, Heideman M and
Berggren H: Altered concentrations of terminal complement
complexes, anaphylatoxins, and leukotrienes in the coronary sinus
during cardiopulmonary bypass. J Cardiothorac Anesth. 3:305–310.
1989. View Article : Google Scholar : PubMed/NCBI
|
24
|
Gluszek J: Ischaemic heart disease and
hypertension in patients with chronic obstructive pulmonary disease
and obstructive sleep apnoea. Pneumonol Alergol Pol. 81:567–574.
2013.(In Polish). PubMed/NCBI
|